![]() Wait time was not associated with grade change (P>.05). Upgrading of the tumor to grade 3 in the hysterectomy specimen was seen in 4.7% of 321 tumors classified as grade 1 and 18.4% of 114 tumors classified as grade 2 on the endometrial biopsy, respectively. Median wait time was 57 days (range 1-177 days) among 435 patients. Time interval and grade change between endometrial biopsy and hysterectomy were correlated to demographics and survival outcomes. Patients who received neoadjuvant chemotherapy or hormonal treatment were excluded. A retrospective study was conducted to examine patients with grade 1 and 2 endometrioid adenocarcinoma diagnosed by preoperative endometrial biopsy who subsequently underwent hysterectomy-based surgical staging between 20. To examine whether wait time between endometrial biopsy and surgical staging correlates with tumor characteristics and affects survival outcomes in patients with type I endometrial cancer. Matsuo, Koji Opper, Neisha R Ciccone, Marcia A Garcia, Jocelyn Tierney, Katherine E Baba, Tsukasa Muderspach, Laila I Roman, Lynda D Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Names Biopsy - endometrium Images Pelvic laparoscopy Female reproductive anatomy Endometrial biopsy Uterus Endometrial biopsy References Beard JM, Osborn J. In addition, it could be used in screening for endometrial malignancies on a broader scale. Our liquid-based endometrial cytology would be more appropriate in various clinical situations as the initial detection tool for endometrial malignancies, rather than suction endometrial tissue biopsy. However, there were still no significant differences among all the performance values. ![]() When the positivity threshold was more than "atypical endometrial cells of undetermined significance," the rate of positive liquid-based endometrial cytology from cases with a positive final histology (84.5%) was higher than the rate of positive suction endometrial tissue biopsy from cases with a positive final histology (69.8%). ![]() None of the clinical performance values of liquid-based endometrial cytology for detecting the endometrial malignancies were statistically inferior to those of the suction endometrial tissue biopsy. The rate of nonpositive final histology in nonpositive liquid-based endometrial cytology (98.2%) was higher than the rate of nonpositive final histology in nonpositive suction endometrial tissue biopsy (97.0%). From November 2011 to May 2013, we consecutively collected 1,118 liquid-based endometrial cytology specimens and 674 suction endometrial tissue biopsy specimens. We evaluated the clinical performance of liquid-based endometrial cytology (SurePathâ„¢) for detecting endometrial malignancies by comparison with the performance of suction endometrial tissue biopsy. Yanaki, Fumiko Hirai, Yasuo Hanada, Azusa Ishitani, Ken Matsui, Hideo Liquid-Based Endometrial Cytology Using SurePathâ„¢ Is Not Inferior to Suction Endometrial Tissue Biopsy in Clinical Performance for Detecting Endometrial Cancer Including Atypical Endometrial Hyperplasia. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |